Skip to main content

Table 3 Number of probe sets that significantly differed in expression (p ≤ 0.001).

From: Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment

Fold Change Expected* Day 3 Day 6 Day 10 Day 13 Day 27 Day 42 Day 70
NA** 11 973 478 725 471 716 452 920
≥ 1.5 -† 290 165 255 142 194 157 289
%≥ 1.5   30% 35% 35% 30% 27% 35% 31%
Up regulated         
Fold Change Expected* Day 3 Day 6 Day 10 Day 13 Day 27 Day 42 Day 70
NA** -† 472 237 344 229 340 234 406
≥ 1.5 -† 235 96 294 102 129 103 206
%≥ 1.5   50% 41% 85% 45% 38% 44% 51%
Down regulated         
Fold Change Expected* Day 3 Day 6 Day 10 Day 13 Day 27 Day 42 Day 70
NA** -† 501 241 381 242 376 218 514
≤ -1.5 -† 55 32 61 40 65 54 83
%≥ 1.5   11% 13% 16% 17% 17% 25% 16%
  1. * Expected for normal distribution
  2. ** Not applicable; No fold change cutoff applied
  3. † Not applicable